|
|
| SNC-80 |
|
| CHEBI:231727 |
|
| A member of the class of alkylpiperazines that is piperazine substituted by (R)-[4-(diethylcarbamoyl)phenyl](3-methoxyphenyl)methyl, methyl, prop-1-en-3-yl, and methyl groups at positions 1, 2S, 4, and 5R, respectively. It is a δ-opioid receptor agonist that exhibits antidepressant, anxiolytic, analgesic, and antineoplastic activities. |
|
This entity has been manually annotated by the ChEBI Team.
|
|
Joan Glenny Pescov
|
|
|
|
|
|
Molfile
XML
SDF
|
|
|
|
|
InChI=1S/C28H39N3O2/c1- 7-17-30-19-22(5)31(20-21(30)4)27(25-11-10-12-26(18-25)33-6)23-13-15-24(16-14-23)28(32)29(8-2)9-3/h7,10-16,18,21-22,27H,1,8-9,17,19-20H2,2-6H3/t21-,22+,27-/m1/s1 |
| KQWVAUSXZDRQPZ-UMTXDNHDSA-N |
| [H][C@@](N1C[C@@H](C)N(CC=C)C[C@@H]1C)(C1=CC=C(C=C1)C(=O)N(CC)CC)C1=CC(OC)=CC=C1 |
|
|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
|
delta-opioid receptor agonist
A compound that exhibits agonist activity at the delta-opioid receptor.
opioid analgesic
A narcotic or opioid substance, synthetic or semisynthetic agent producing profound analgesia, drowsiness, and changes in mood.
|
|
|
convulsant
A drug that induces seizures or increases their severity.
delta-opioid receptor agonist
A compound that exhibits agonist activity at the delta-opioid receptor.
antidepressant
Antidepressants are mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions.
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
anxiolytic drug
Anxiolytic drugs are agents that alleviate anxiety, tension, and anxiety disorders, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions.
opioid analgesic
A narcotic or opioid substance, synthetic or semisynthetic agent producing profound analgesia, drowsiness, and changes in mood.
|
|
View more via ChEBI Ontology
|
4-[(R)-[(2S,5R)-2,5-dimethyl-4-(prop-2-en-1-yl)piperazin-1-yl](3-methoxyphenyl)methyl]-N,N-diethylbenzamide
|
|
(+)-4-[(αR)-α-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide
|
ChEBI
|
|
4-[(R)-[(2S,5R)-2,5-dimethyl-4-(2-propen-1-yl)-1-piperazinyl](3-methoxyphenyl)methyl]-N,N-diethylbenzamide
|
ChEBI
|
|
SNC 80
|
ChEBI
|
|
SNC80
|
ChEBI
|
|
156727-74-1
|
CAS Registry Number
|
ChEBI
|
|
10340622
|
PubMed citation
|
Europe PMC
|
|
10340623
|
PubMed citation
|
Europe PMC
|
|
10841355
|
PubMed citation
|
Europe PMC
|
|
10973516
|
PubMed citation
|
Europe PMC
|
|
11400911
|
PubMed citation
|
Europe PMC
|
|
11731107
|
PubMed citation
|
Europe PMC
|
|
12717105
|
PubMed citation
|
Europe PMC
|
|
15032699
|
PubMed citation
|
Europe PMC
|
|
15102931
|
PubMed citation
|
Europe PMC
|
|
15792997
|
PubMed citation
|
Europe PMC
|
|
15936000
|
PubMed citation
|
Europe PMC
|
|
15938001
|
PubMed citation
|
Europe PMC
|
|
16334142
|
PubMed citation
|
Europe PMC
|
|
16696856
|
PubMed citation
|
Europe PMC
|
|
17061517
|
PubMed citation
|
Europe PMC
|
|
18258789
|
PubMed citation
|
Europe PMC
|
|
18469844
|
PubMed citation
|
Europe PMC
|
|
22134006
|
PubMed citation
|
Europe PMC
|
|
29278419
|
PubMed citation
|
Europe PMC
|
|
29589835
|
PubMed citation
|
Europe PMC
|
|
29727730
|
PubMed citation
|
Europe PMC
|
|
31553899
|
PubMed citation
|
Europe PMC
|
|
33516811
|
PubMed citation
|
Europe PMC
|
|
35104493
|
PubMed citation
|
Europe PMC
|
|
36708979
|
PubMed citation
|
Europe PMC
|
|
37060527
|
PubMed citation
|
Europe PMC
|
|
39064909
|
PubMed citation
|
Europe PMC
|
|
7714789
|
PubMed citation
|
Europe PMC
|
|
8035418
|
PubMed citation
|
Europe PMC
|
|
9548393
|
PubMed citation
|
Europe PMC
|
|
9694952
|
PubMed citation
|
Europe PMC
|
|
9832942
|
PubMed citation
|
Europe PMC
|
|
